MR1 and neoplasm: In a distinct model involving subcutaneous growth of low dose B16F10 melanoma cells, we again found that tumor growth was significantly inhibited in B6-MAITcast MR1−/− mice relative to B6-MAITcast MR1 WT mice, leading to enhanced survival of MAIT cell-deficient mice (Fig. 1b).